Symposium Presentation 16.1
Methylphenidate Hydrochloride Modified Release for Adults with ADHD: A 40-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy, and Safety Study
Thursday, October 24, 2013 8:30 AM
Michael Huss, MD, Department of Child and Adolescent Psychiatry, University of Medicine, Mainz, Germany
Ylva Ginsberg, MD, PhD, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
Torbjorn Tvedten, MD, Centre for Therapy and Supervision, Skien, Norway
Torben Arngrim, MD, Ciconia Aarhus Private Hospital, Aarhus, Denmark
Daniel Gruener, MD, CRI Lifetree, Huntingdon Valley
Jerry Steiert, MD, Summit Research Network, Seattle, WA
Alexandra Philipsen, MD, Department of Psychiatry and Psychotherapy, University Medical Center Freiburg, Freiburg, Germany
Michael Greenbaum, MD, Capstone Clinical Research, Libertyville, IL
Katherine Carter, PharmD, Novartis Pharmaceutical Corporation, East Hanover, NJ
Chien-Wei Chen, Novartis Pharmaceutical Corporation, East Hanover, NJ
Vinod Kumar, MD, Novartis Pharmaceutical Corporation, East Hanover, NJ
